Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Al Razi Medical CoSAU:9572 -0.13%45 Gross Margin % is 25.26% as of Dec. 2025, which is 9% below its 10-year median of 27.86. GuruFocus rates SAU:9572 with a GF Score™ of 45/100 and a GF Value™ of ﷼64.47 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 629 Healthcare Providers & Services companies, Al Razi Medical Co ranks worse than 73.93% on this metric.
The historical rank and industry rank for Al Razi Medical Co's Gross Margin % or its related term are showing as below:
SAU:9572'
s Gross Margin % Range Over the Past 10 Years
Min: 25.94 Med: 27.86 Max: 30.73
Current: 25.94
During the past 4 years, the highestGross Margin % of Al Razi Medical Co was 30.73%. The lowest was 25.94%. And the median was 27.86%.
SAU:9572's Gross Margin % is ranked worse than 73.93% of 629
companies
in the Healthcare Providers & Services industry
Industry Median: 40.06
vs SAU:9572: 25.94
Al Razi Medical Co had a gross margin of 25.26% for the quarter that ended in Dec. 2025 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Al Razi Medical Co was 0.00% per year.
Al Razi Medical Co (SAU:9572) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Al Razi Medical Co had a gross margin of 25.26% for the quarter that ended in Dec. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Al Razi Medical Co Gross Margin % Related Terms
Al Razi Medical Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for Al Razi Medical Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Al Razi Medical Co Gross Margin % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Al Razi Medical Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Al Razi Medical Co Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Al Razi Medical Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Al Razi Medical Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Al Razi Medical Co (SAU:9572) has a Gross Margin % of 25.26% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Al Razi Medical Co and its competitors. This is near median its historical median of 27.86. Over the past decade, Al Razi Medical Co's Gross Margin % has ranged from 25.94 to 30.73. According to the industry distribution chart, Al Razi Medical Co ranks #465 out of 629 companies in the Healthcare Providers & Services industry, placing it in the top 73.9%.
Is Al Razi Medical Co's Gross Margin % too high?
Al Razi Medical Co's current Gross Margin % of 25.26% is near median its 10-year median of 27.86. Over the past 10 years, this metric has ranged from a low of 25.94 to a high of 30.73. The Healthcare Providers & Services industry median Gross Margin % is 40.06. Al Razi Medical Co's value of 25.26% is 36.9% below this industry median. Based on the distribution chart, Al Razi Medical Co ranks #465 out of 629 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Al Razi Medical Co has a GF Score™ of 45/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Al Razi Medical Co's Gross Margin % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Al Razi Medical Co ranks #465 out of 629 companies for Gross Margin %. This places Al Razi Medical Co in the lower half of its industry. The industry median Gross Margin % is 40.06. Al Razi Medical Co's value of 25.26% is 36.9% below this benchmark. Historically, Al Razi Medical Co's own Gross Margin % has ranged from 25.94 to 30.73 over the past decade. While the company's 10-year median is 27.86 vs. the industry median of 40.06, Al Razi Medical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.06, based on 629 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Al Razi Medical Co's current Gross Margin % of 25.26% is 36.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Al Razi Medical Co and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Al Razi Medical Co's current Gross Margin % is 25.26%, which is near median its own 10-year median of 27.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Al Razi Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Al Razi Medical Co (SAU:9572) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼64.47, compared to a current price of ﷼30.28 — trading 53% below its estimated fair value. The current Gross Margin % is 25.26%, which is near median its 10-year median of 27.86 and 36.9% below the Healthcare Providers & Services industry median of 40.06. Al Razi Medical Co's overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Al Razi Medical Co (SAU:9572), the current Gross Margin % is 25.26% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Al Razi Medical Co (SAU:9572) Overvalued in 2026?
Based on GuruFocus' analysis, Al Razi Medical Co stock appears to be undervalued.
The current stock price of ﷼30.28 is trading 53% below its estimated GF Value™ of ﷼64.47.
GuruFocus considers Al Razi Medical Co to be Significantly Undervalued.
Key valuation signals for SAU:9572:
Gross Margin %: 25.26% (near median its 10-year median of 27.86)
GF Value™: ﷼64.47 vs. price of ﷼30.28 (53% below fair value)
Industry Position: 36.9% below the Healthcare Providers & Services median (#465 of 629)
No single metric tells the full story. See the SAU:9572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Al Razi Medical Co operates in the medical field in the Kingdom of Saudi Arabia. The company provides all pharmaceutical and cosmetic products. It engages in buying and selling pharmaceuticals, medical supplies, herbal and cosmetic products, and all related products on a wholesale and retail basis.
45GF Score
Get the complete analysis for SAU:9572
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9572 has been successfully added to your 
